Recombinant activated factor VII (rFVIIa) as salvage treatment for intractable hemorrhage
BACKGROUND: Recently, there has been an increased use of recombinant activated factor VII (rFVIIa) to promote hemostasis in various hemorrhagic conditions. The objective of this study was to determine the outcome of patients treated with rFVIIa who had intractable bleeding associated with cardiac su...
Guardat en:
| Publicat a: | Thromb J |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2004
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC535534/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15530167/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1477-9560-2-9 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|